Neurological Disease Genetic Panels

Neurological genetic tests investigate genetic changes associated with diseases affecting the brain and nervous system. They can help evaluate the genetic causes of Alzheimer's disease, Parkinson's disease, epilepsy and neurodevelopmental disorders. The information obtained can support the diagnostic process and, in suitable patients, contribute to follow-up, treatment and family counseling.

Who is it suitable for?

1. With a specialist physician's evaluation, genetic testing may be considered in the following people:
2. People with a hereditary neurological disease or a known genetic change in their family.
3. People with early-onset Alzheimer's or Parkinson's disease, or with more than one affected person in the family.
4. People with epilepsy of suspected genetic origin or with unexplained seizures.
5. Children for whom genetic investigation is recommended because of developmental delay, intellectual disability or autism spectrum disorder. As a first step, exome sequencing and/or microarray, as well as fragile X analysis, are recommended; gene panels are not a substitute for these, and a negative panel result does not rule out a genetic cause.
6. People whose neurological symptoms remain unexplained despite clinical evaluations.

The appropriate test is selected by a neurology and/or medical genetics specialist according to the person's symptoms and family history. The detection of a genetic predisposition does not necessarily mean that the disease will develop.

During working hours, you can quickly apply with a simple blood test by visiting our Nicosia or Kyrenia laboratory branches.